Research shows that ApoE4, the greatest genetic risk factor of Alzheimers, may make people more vulnerable to COVID-19. But scientists say we cant leap to conclusions: There is still much to learn about the novel coronavirus.
Amid growing evidence of the neurological complications of COVID-19, which range from loss of sense of taste and smell, to brain fog, to stroke and brain damage, research are trying to understand what could lead to these neurological symptoms in some patients and not others.
A recent stem cell study suggests ApoE4 may be a part of the equation, finding that the virus may worsen the effects of an infection in certain cells of the genetic variant compared to their ApoE3 counterparts.
Vaithilingaraja Arumugaswami, an author of the study and a member of Broad Stem Cell Research Center at the University of California, Los Angeles, said the findings demonstrate that ApoE4 may be one variable that influences some peoples likelihood of experiencing severe COVID-19 symptoms.
COVID-19 is a complex disease, and we are beginning to understand the risk factors involved in the manifestation of the severe form of the disease Arumugaswami said in a news release. Our cell-based study provides a possible explanation as to why individuals with Alzheimers disease are at increased risk of developing more severe COVID-19 symptoms.
In the study published in Cell Stem Cell, Arumugaswami and colleagues investigated brain cells response to SARS-CoV-2, the virus responsible for COVID-19, with models created from pluripotent stem cells (iPSCs), a type of stem cell that enables scientists to create virtually any type of cells and build human tissue.
After confirming that neurons and astrocytes could indeed be infected with SARS-CoV-2, the team wondered whether the presence of astrocytes cells that are critical to the function of the central nervous system would aggravate a SARS-CoV-2 infection. The scientists found higher rates of infection in brain models and cell cultures with astrocytes compared to those without, an indication that astrocytes could boost the rate of a SARS-CoV-2 infection.
The researchers then assessed whether ApoE could influence cells response to an infection.
Past research can offer some clues: Scientists have previously detected higher viral loads of herpes simplex virus type 1 in the brains of ApoE4 mice than ApoE3 mice. In human immunodeficiency virus type 1, the genetic variant is linked with accelerated progression of the disease compared with ApoE3. In the case of SARS-CoV-2, recent studies suggest that ApoE4 carriers are not only at higher risk of contracting the virus, but they are also more likely to develop severe complications of an infection.
Arumugaswami and colleagues found that ApoE4 neurons and astrocytes seemed more susceptible to an infection compared to their ApoE3 counterparts.
The ApoE4 cells also responded differently to the invading virus and suffered greater damage than ApoE3 cells. Infected ApoE4 astrocytes had fatter bodies and greater fragments in the their command centers than infected ApoE3 astrocytes. Meanwhile, infected ApoE4 neurons not only had shorter signalling branches, but the cells also grew less of them.
Dr. Aaron Ritter, associate staff of neuropsychiatry and behavioral neurology at the Cleveland Clinic Lou Ruvo Center for Brain Health who was not involved in the study, noted that there are significant differences between what happens in cells grown in petri dishes compared to the human brain.
Jessica Young, assistant professor of laboratory medicine and pathology at the University of Washington, agreed, adding that genetics is among many factors like lifestyle that influence peoples biological response to diseases.
Most human diseases are going to be caused by an interaction between someones genetics and their environment, Young, who was not involved in the study, told Being Patient. Whats cool about this type of work is that it separates that out. Stem cell studies can really test what the effects of genetics are.
[The researchers] made ApoE4 cells, compared them to ApoE3 cells, and they saw a distinct effect. Thats a very neat and powerful way to use this type of model to get at the molecular questions, as long as the caveats are understood.
Dr. Ritter said the study findings may not be relevant to most people as the protective barrier of the central nervous system known as the blood-brain barrier seems to be highly effective at limiting the ability of viruses to enter the brain. And, the blood-brain barrier was not included in the study, which the authors acknowledged to be a limitation of their research.
According to Dr. Ritter, the jury is still out about whether ApoE4 carriers are at higher risk of an infection and the neurological symptoms of COVID-19. He wrote in an email, There is still so much to be learned from this virus.
He noted that the recent study does show that there are unknown factors including genetics that may influence biological responses to a SARS-CoV-2 infection. So, people who believe they are unlikely to develop severe complications should practice COVID-19 safety protocols just as diligently as those with well-established risk factors.
There are a number of factors that could make a person more susceptible to severe infection, Dr. Ritter said, some of these factors are well known: underlying respiratory illnesses [like chronic obstructive pulmonary disease], smoking, medical comorbidities, age, etc.
But this study also shows that factors we arent aware [of such as genetics] may play an important role at the biological level. This means that even people who may consider themselves low risk may, in actuality, harbor risk at a level we dont understand. As a result, its still important that each one of us take all the necessary precautions to prevent transmission.
Contact Nicholas Chan at firstname.lastname@example.org
View original post here:
- Fascination with stem cell sensation leads to Fulbright scholarship - Monash University - May 12th, 2021
- The Competitive Zeal To Decide The Dimensions Of Growth Of The Induced Pluripotent Stem Cells Market The Courier - The Courier - May 12th, 2021
- Gene therapy offers potential cure to children born without an immune system - UCLA Newsroom - May 12th, 2021
- With $52 Million Series A, Appia Bio Anticipates a Bright Future in Cell Therapy - BioSpace - May 12th, 2021
- Advanced Therapy Medicinal Products Market Size Worth $21.2 Billion By 2028: Grand View Research, Inc. - PRNewswire - May 12th, 2021
- The Univer-cell Alchemist: Dr Subhadra Dravidas breakthrough research on novel stem cell treatment for Covid patients - The New Indian Express - May 10th, 2021
- Stem Cell Therapy Market 2021-2026: Industry Analysis, Geographical Segmentation, Drivers, Challenges, and Trend & Forecasts KSU | The Sentinel... - May 9th, 2021
- Hope, hype and exploitation the wild history of stem cell science - ABC News - May 2nd, 2021
- Scientists create first-of-its-kind 3D organoid model of the human pancreas - Newswise - May 2nd, 2021
- Researchers map the first complete atlas of single cells that make up the human teeth - News-Medical.net - April 30th, 2021
- Researchers develop first 3D organoid models of the pancreas from human stem cells - News-Medical.net - April 30th, 2021
- The first comprehensive single-cell atlas of human teeth - Newswise - April 30th, 2021
- Revotek Deploys Its Bioink Technology to Research Institutes - PRNewswire - April 30th, 2021
- Rocket Pharmaceuticals Announces Upcoming Clinical Data Presentations at the 24th Annual Meeting of the American Society of Gene and Cell Therapy -... - April 30th, 2021
- Controversial experiment with human cells growing in monkey embryos | Science and Health - SwordsToday.ie - April 30th, 2021
- Adipose Tissue-Derived Stem Cells (ADSCS) Market Value with Volume and Growth Prospects 2021 to 2027 The Courier - The Courier - April 30th, 2021
- Placental-derived stem cell therapy shows promise to heal intestinal disease in premature babies - News-Medical.Net - April 28th, 2021
- Tissue Regeneration Market: Stem Cell Therapy to be Highly Attractive Segment - BioSpace - April 28th, 2021
- Repairing stroke and Alzheimer's disease damage with stem cell therapy - Health Europa - April 28th, 2021
- Stem Cell Therapy Global Market Report 2021: COVID-19 Growth And Change To 2030 - Yahoo Finance - April 28th, 2021
- Poseida Therapeutics to Present at American Society of Gene and Cell Therapy 2021 Annual Meeting - PRNewswire - April 28th, 2021
- Vitro Biopharma Inc. January 31st 2021, 1st Quarter ended Financial Results of Operations and Shareholder Letter - Benzinga - April 28th, 2021
- Longeveron Selected to Present at the 2021 World Stem Cell Summit - GlobeNewswire - April 28th, 2021
- Prostate organoid technology - the new POT of gold in prostate stem cell and cancer research - DocWire News - April 28th, 2021
- University of Illinois Urbana-Champaign and Mayo Clinic Researchers Develop New Technique to Study 'Microcancers' and Screen Cancer-Fighting Drugs -... - April 28th, 2021
- Research with fetal tissue from elective abortion called 'deeply offensive' - Catholic San Francisco - April 28th, 2021
- Integration of Cellular Therapy Jumpstarts Research Efforts in Acute Leukemias - OncLive - April 28th, 2021
- Stem Cell Therapy for Diabetes and Related Conditions Market 2021 Competitive Insights Sanofi, Novo Nordisk, Mesoblast, Caladrius Biosciences,... - April 26th, 2021
- This technology was designed to grow human cells. Now it's transforming the cultured meat industry. - Massive Science - April 26th, 2021
- Global Canine Stem Cell Therapy Market is Projected to Grow at a CAGR of 9.3% during (2018 2026) NeighborWebSJ - NeighborWebSJ - April 26th, 2021
- Top Key-Players To Be Restored To The First Position In The Recombinant Cell Culture Supplements Market The Courier - The Courier - April 26th, 2021
- Hematopoietic Stem Cell Transplantation (HSCT) Global Market Report (2020-2027) Segmented by Type, Application and region (NA, EU, and etc.) The... - April 26th, 2021
- Three-dimensional microscale hanging drop arrays with geometric control for drug screening and live tissue imaging - Science Advances - April 24th, 2021
- Stem Cell Banking Market: Rise in Incidence of Chronic Conditions to Drive the Market - BioSpace - April 24th, 2021
- How Brown neuroscientists are using CRISPR to accelerate brain research and more - Brown University - April 24th, 2021
- Biotechnology in BCfuture treatments and potential cures for cancer - UBC Faculty of Medicine - UBC Faculty of Medicine - April 24th, 2021
- Scientists have moved closer to making organisms that are part human and part animal - Scroll.in - April 24th, 2021
- Impact of COVID-19 on Stem Cell Therapy Market is Booming Worldwide with Magellan, Medipost Co., Ltd, Osiris Therapeutics, Inc., Kolon TissueGene,... - April 24th, 2021
- Single-Use Bioreactors Market by Type of Reactor, Scale of Operation, Cell Culture System, Type of Molecule, Application Area, Purpose, End-User, and... - April 24th, 2021
- Stem cell therapy promotes recovery from stroke and dementia in mice - UCLA Newsroom - April 22nd, 2021
- Accelerating Cures Through Research - New York Stem Cell ... - April 22nd, 2021
- Stem cell therapy can repair brain damage and improve memory function in mice - News-Medical.Net - April 22nd, 2021
- 'Re-imagining' mice and men - The Highland County Press - April 22nd, 2021
- Research with fetal tissue from elective abortion called 'deeply offensive' - The Catholic Sun - April 22nd, 2021
- Research with fetal tissue from abortion called 'deeply offensive' - CatholicPhilly.com - April 22nd, 2021
- Do our brains age faster than the rest of our bodies? - ScienceBlog.com - April 22nd, 2021
- Study discovers mechanism involved in the development of metaplasia in the esophagus - News-Medical.Net - April 22nd, 2021
- Research Reveals Distinct Types of Cells That May Be Involved in Breathing-Related Diseases in Infants - Technology Networks - April 22nd, 2021
- Breakthrough Paper Outlines Path to Heart Regeneration After Cardiac Injury - PR Web - April 22nd, 2021
- Stem Cells Market to Witness Robust Expansion Throughout the Forecast Period 2018-2026 KSU | The Sentinel Newspaper - KSU | The Sentinel Newspaper - April 20th, 2021
- Animal Stem Cell Therapy Market Study Report and In-deep Analysis 2020 2026 The Courier - The Courier - April 20th, 2021
- Global Cord Blood Stem Cells Market to 2026 Industry Perspective, Comprehensive Analysis, and Forecast KSU | The Sentinel Newspaper - KSU | The... - April 20th, 2021
- Evaluation of the UK Myeloma Research Alliance Risk Profile in Chinese Patients with Newly Diagnosed Multiple Myeloma without Autologous Stem Cell... - April 18th, 2021
- StemSynergy Therapeutics' Notch1-Selective Small Molecule Inhibitor Prevents Tumor Growth by Ablation of Cancer Stem Cells - Business Wire - April 16th, 2021
- US researchers create the first human-monkey chimaera, in the midst of a raging debate on such experimentation - The Financial Express - April 16th, 2021
- CAR T-Cell Therapy Enters the Arena in Multiple Myeloma With Ongoing Research Ahead - OncLive - April 16th, 2021
- Treating chronic myeloid leukemia (CML): By phase and more - Medical News Today - April 16th, 2021
- Cellino Biotech developing tech to help scale stem cell therapies - MedCity News - April 14th, 2021
- Global Induced Pluripotent Stem Cell (iPS Cell) Industry Report 2021: Methods of Commercializing iPSCs are Diverse and Continue to Expand -... - April 14th, 2021
- A Massive New Gene Editing Project Is Out to Crush Alzheimer's - Singularity Hub - April 14th, 2021
- eQcell Inc Announces the Appointment of Members of the Board of Directors - BioSpace - April 14th, 2021
- Researchers Receive Grant to Improve Cellular Therapies to Treat 'Incurable' Diseases - University of Arkansas Newswire - April 14th, 2021
- Lonza Celebrates 20th Anniversary of Nucleofector Cell Transfection Platform - Technology Networks - April 14th, 2021
- New consortium aims to accelerate development of stem cell-based therapies for Huntingtons disease - News-Medical.Net - April 10th, 2021
- Strengthening the Stem Cell Industry Through Better Regulation - The Regulatory Review - April 10th, 2021
- Global Induced Pluripotent Stem Cell (iPS Cell) Industry Report 2021: Research, Patents, Funding Events, Industry Partnerships, Biomedical... - April 10th, 2021
- Stem Cell Transplantation May Be Offered Less Often as a Treatment Option for Some Patients with Mantle Cell Lymphoma - Curetoday.com - April 10th, 2021
- Real-time imaging shines light on the coordination of neural stem cell activation - News-Medical.net - April 10th, 2021
- Searching for Molecular Targets in Myeloid Malignancies and Beyond - OncLive - April 10th, 2021
- Fitore Nutrition Launches Spectrum + to Better the Lives of Children With Autism - Influencive - April 10th, 2021
- Cancer Stem Cells Market By Size Estimation, Growth Rate, Regional Analysis With with the CAGR of 11.0% Over the Forecast Period. KSU | The Sentinel... - April 10th, 2021
- global market for regenerative medicines is predicted to grow at a CAGR of 13.99% over the forecast period of 2020-2030 - GlobeNewswire - April 10th, 2021
- Adipose Derived Stem Cell Therapy Market New Business Opportunities And Investment Research Report 2020-2027 | Coherent Market Insights KSU | The... - April 10th, 2021
- Celularity Announces Multiple Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2021 - GlobeNewswire - April 10th, 2021
- New local publication and book-signing event - Bowling Green Daily News - April 6th, 2021
- Human blastocyst-like structures generated entirely from pluripotent stem cells. Shifting the paradigm of developmental biology? - ESHRE - April 3rd, 2021
- Comprehensive Report on Stem Cell Therapy Market 2021 | Size, Growth, Demand, Opportunities & Forecast To 2026 | Cellular Dynamics... - April 3rd, 2021
- New approach to CAR T gene therapy yields efficient and longer-lasting response against HIV - News-Medical.Net - April 3rd, 2021
- New research offers hope to women with POI - Austin Daily Herald - Austin Herald - April 3rd, 2021
- Stem Cell Therapy Market to Witness Strong Growth Over 2021-2027 | Key Manufacturers Overview- Osiris Therapeutics, NuVasive, Chiesi Pharmaceuticals,... - April 3rd, 2021